HHS Secretary Alex Azar: Agency's 2019 budget makes 'significant investments' in its goals 

Washington DC National Capitol Building
HHS Secretary Alex Azar went before a House committee Thursday to defend the agency's 2019 budget. (Getty/lucky-photographer)

Alex Azar, secretary of the Department of Health and Human Services, went before Congress to once again defend the Trump administration's 2019 budget for the agency. 

The proposed budget "strongly supports ongoing work HHS does," Azar told the House Committee on Appropriations' Subcommittee on Labor, Health and Human Services, Education and Related Agencies on Thursday morning.

Azar previously testified on the budget before the House Ways and Means Committee and made a similar argument that the proposed funding levels back central HHS priorities like combatting the opioid epidemic and fostering the healthcare industry's transition to value-based care. 

Free Webinar

Take Control of Your Escalating Claim Costs through a Comprehensive Pre-payment Hospital Bill Review Solution

Today managing high dollar claim spend is more important than ever for Health Plans, TPAs, Employers, and Reinsurers, and can pose significant financial risks. How can these costs be managed without being a constant financial drain on your company resources? Our combination of the right people and the right technology provides an approach that ensures claims are paid right, the first time. Register Now!
Alex Azar
HHS Secretary Alex Azar (Wwsgconnect)

"The budget makes significant strategic investments in HHS' work," Azar said Thursday. 

RELATED: HHS Secretary Alex Azar outlines 4-point plan to accelerate shift toward a value-based system  

The White House's initial budget for fiscal year 2019 proposed $68.4 billion in funding to HHS, a 17% cut. However, after Congress reached a two-year funding agreement, the Office of Management and Budget issued an addendum that boosted HHS' allocation by $27 billion. 

Representatives from both sides of the aisle highlighted some of the positives in the budget—including $10 billion for opioid programs—but also expressed concern about cuts to programs at agencies such as the Centers for Disease Control and Prevention and the National Institutes of Health. 

Rep. Rosa DeLauro, D-Conn., the subcommittee's ranking member, said there's "no amount of magical accounting" that can fund programs facing significant cuts, such as the Agency for Healthcare Research and Quality. 

"It's like playing Three-card Monte with funding for life-saving programs," DeLauro said. 

Rep. Rodney Frelinghuysen, R-New Jersey, who chairs the full appropriations committee, said that concerns about cuts to agencies such as NIH are worrying to members of both parties, as NIH, CDC and other such groups enjoy bipartisan backing. 

He also noted that the budget guts investments to the healthcare workforce, which also has bipartisan support.  

RELATED: Health IT winners and losers in Trump's budget proposal—Cybersecurity gets a boost, ONC sees a 37% cut 

Democrats on the panel expressed concern about elements in the budget that anticipate a repeal of the Affordable Care Act and new initiatives at HHS that could make it harder for some women to access contraceptive coverage. 

Rep. Nita Lowey, D-N.Y., the appropriation committee's ranking member, said that it's evident that the Trump administration doesn't "care about women having access to affordable birth control." She expressed concern that recent changes, such as the agency's new focus on religious freedom, could pose significant barriers to women accessing care they need, and might even lead to an increase in unwanted pregnancies. 

Azar said HHS is working to find a middle ground between access to contraceptive coverage and moral and religious objections from companies. 

"We're trying to balance strike a delicate balance between very important interests on all sides," Azar said. 

A video of the full hearing is embedded below: 

 

Suggested Articles

CMS is proposed to lower the user fee for ACA exchange insurers and wants to enable the private sector to develop competing signup websites.

JetBlue, Lufthansa, Swiss International Airlines, United Airlines, and Virgin Atlantic will roll out the CommonPass mobile app in December.

With the distribution of a COVID-19 vaccine looming, companies in the pharmaceutical supply chain are working overtime to plan for all contingencies.